NASDAQ
Alzamend Neuro, Inc. (ALZN) has a current ratio of 6.58x as of Monday, May 25, 2026. This represents a 48.01% increase compared to its 12-month average of 4.45x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.